X
X
Total 393357 Results
| Label | Description | ILX | Version | Created CID | Modified Time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Delayed phase | A phase which starts later than the natural start time. | ILX:0102994 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delayed recall test | A task in which participants are given information to remember (list of words or paragraph) and which they are asked to reproduce after some span of time. | ILX:0102995 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delayed response task | No definition submitted yet. | ILX:0102996 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Channel Total Time | Total amount of time actually delivered between Control Point 0 and final Control Point of the Brachy Control Point Sequence (300A,02D0) for current Channel (sec). | ILX:0102997 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Meterset | Machine setting actually delivered at current control point. | ILX:0102998 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Number of Pulses | Number of Pulses actually delivered per fraction for current Channel. Required if Brachy Treatment Type (300A,0202) is PDR. | ILX:0102999 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Primary Meterset | Machine setting actually delivered as recorded by primary meterset. | ILX:0103000 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Pulse Repetition Interval | Pulse repetition interval (sec) actually delivered for current Channel. Required if Brachy Treatment Type (300A,0202) is PDR. | ILX:0103001 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Secondary Meterset | Machine setting actually delivered as recorded by secondary meterset. | ILX:0103002 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivered Treatment Time | Treatment Time actually delivered (sec). | ILX:0103003 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivery Maximum Dose | The maximum dose (in Gy) which can be delivered to the dose reference. | ILX:0103004 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delivery Warning Dose | The dose (in Gy) that when reached or exceeded should cause some action to be taken. | ILX:0103005 | 6 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Delphinapterus | ILX:0103006 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Delphinapterus leucas | ILX:0103007 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Delphinidae | ILX:0103008 | 5 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Delta 71-82 Alpha-Synuclein Drosophila | This transgenic drosophila expresses a form of alpha-synuclein with a deletion in the NAC domain that removes amino acids 71-82. This mutated alpha-synuclein is unable to aggregate in vitro in a transgenic Drosophila model. There are no alpha-synclein aggregates and no loss of tyrosine hydroxylase- positive neurons. This mutation is used to investigate the importance of alpha-synuclein aggregation on neurodegenerative diseases like Parkinson's Disease. | ILX:0103009 | 5 | scicrunch | 08/24/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Delta receptor | ILX:0103010 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Delta wave | is a high amplitude brain wave with a frequency of 1–4 hertz which can be recorded with an electroencephalogram (EEG) and is usually associated with slow-wave sleep. Delta wave activity occurs most frequently during stage N3 slow-wave sleep, accounting for 20% or more of the EEG record during this stage. These waves are believed to originate in the thalamus in coordination with the reticular formation (adapted from Wikipedia). | ILX:0103011 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Delta1-dihydrotestosterone | Not Available Pharmacology: Not Available Mechanism of action: Not Available Drug type: Experimental. Illicit. Small Molecule. Drug category: | ILX:0103012 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| DeltaFosB | ILX:0103013 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
About
Base community for the SciCrunch.org infrastructure
Contact Us
X